Inotek Pharmaceuticals' Series E Round

Inotek Pharmaceuticals raised a round of funding on September 27, 2013.

Inotek Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs to address serious diseases of the eye. Inotek scientists have identified a deep pipeline of drug ca…

Articles about Inotek Pharmaceuticals' Series E Round: